Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones12-18

DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rallied 2.09% to $740.01 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.39% to 6,050.61 and Dow Jones Industrial Average falling 0.61% to 43,449.90.

The stock's rise snapped a five-day losing streak.

Regeneron Pharmaceuticals Inc. closed $471.19 below its 52-week high ($1,211.20), which the company reached on August 27th.

The stock outperformed some of its competitors Tuesday, as Amgen Inc. $(AMGN)$ fell 0.21% to $265.95, Moderna Inc. $(MRNA)$ fell 2.58% to $40.76, and Gilead Sciences Inc. $(GILD)$ rose 0.81% to $92.80.

Trading volume (974,432) eclipsed its 50-day average volume of 811,967.

Data source: Dow Jones Market Data, FactSet. Data compiled December 17, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

December 17, 2024 16:46 ET (21:46 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492915643?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-18 05:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492915643","market":"hk","top_or_hot":-1,"title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Regeneron Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/REGN\">$(REGN)$</a> rallied 2.09% to $740.01 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&amp;P 500 Index  falling 0.39% to 6,050.61 and Dow Jones Industrial Average  falling 0.61% to 43,449.90. \n</p>\n<p>\n     The stock's rise snapped a five-day losing streak. \n</p>\n<p>\n     Regeneron Pharmaceuticals Inc. closed $471.19 below its 52-week high ($1,211.20), which the company reached on August 27th. \n</p>\n<p>\n     The stock outperformed some of its competitors Tuesday, as Amgen Inc. <a href=\"https://laohu8.com/S/AMGN\">$(AMGN)$</a> fell 0.21% to $265.95, Moderna Inc. <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> fell 2.58% to $40.76, and Gilead Sciences Inc. <a href=\"https://laohu8.com/S/GILD\">$(GILD)$</a> rose 0.81% to $92.80. \n</p>\n<p>\n     Trading volume (974,432) eclipsed its 50-day average volume of 811,967. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 17, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 17, 2024 16:46 ET (21:46 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-18 05:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REGN","symbol_name":"再生元制药公司","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2492915643","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492915643","pubTimestamp":1734471960,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  rallied 2.09% to $740.01 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.39% to 6,050.61 and Dow Jones Industrial Average  falling 0.61% to 43,449.90.The stock's rise snapped a five-day losing streak.Regeneron Pharmaceuticals Inc. closed $471.19 below its 52-week high , which the company reached on August 27th.The stock outperformed some of its competitors Tuesday, as Amgen Inc.  fell 0.21% to $265.95, Moderna Inc.  fell 2.58% to $40.76, and Gilead Sciences Inc.  rose 0.81% to $92.80.Trading volume  eclipsed its 50-day average volume of 811,967.Data source: Dow Jones Market Data, FactSet. Data compiled December 17, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Stre","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"REGN":"再生元制药公司"},"translate_title":"再生元制药公司股票在强劲交易日表现优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REGN":1},"content_text":"DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rallied 2.09% to $740.01 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index  falling 0.39% to 6,050.61 and Dow Jones Industrial Average  falling 0.61% to 43,449.90. \n\n\n     The stock's rise snapped a five-day losing streak. \n\n\n     Regeneron Pharmaceuticals Inc. closed $471.19 below its 52-week high ($1,211.20), which the company reached on August 27th. \n\n\n     The stock outperformed some of its competitors Tuesday, as Amgen Inc. $(AMGN)$ fell 0.21% to $265.95, Moderna Inc. $(MRNA)$ fell 2.58% to $40.76, and Gilead Sciences Inc. $(GILD)$ rose 0.81% to $92.80. \n\n\n     Trading volume (974,432) eclipsed its 50-day average volume of 811,967. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled December 17, 2024. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 17, 2024 16:46 ET (21:46 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492915643"}